All In Biotech

Drug Trial Radar · NCT01969201

FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST)

Randomised Clinical Trial Comparing Highly Purified FSH Formulation (Fostimon®) and Recombinant FSH (Gonal-F®) in GnRH-antagonist Controlled Ovarian Hyperstimulation Cycles.

Last checked: Nov 20, 2026Latest source record: Oct 9, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 710 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

710

Actual

Start

Jan 2014

Primary completion

Jun 2016

Study completion Aug 2017

Sponsor

Lead sponsor
IBSA Institut Biochimique SAIndustry
Sponsor type
Industry
First posted
Oct 25, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 18 years, up to 38 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the non-inferiority study is to evaluate the clinical efficacy and the safety of two different subcutaneous FSH preparations (Fostimon versus Gonal-F) for controlled ovarian hyperstimulation in a GnRH-antagonist cycle.

Conditions

  • Infertility

Interventions

  • UrofollitrophinDrug

  • Follitrophin alphaDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical Pregnancy RateTime frame: 8 weeks

Locations

16 sites in 6 countries. Site status is shown where the registry gives one.

  • UCL- Cliniques Universitaires Saint Luc

    Brussels, Belgium

  • Universitair Ziekenhuis Brussel

    Brussels, Belgium

  • Spedali Civili di Brescia

    Brescia, Italy

  • Fondazione Ca'Granda, Osp Maggiore Policlinico

    Milan, Italy

  • IRCCS San Raffaele

    Milan, Italy

  • Università degli Studi di Napoli 'Federico II'

    Naples, Italy

  • Azienda Ospedaliera Di Reggio Emilia

    Reggio Emilia, Italy

  • Clinica IVI Alicante

    Alicante, Spain

  • Institut Universitari Dexeus

    Barcelona, Spain

  • Ginefiv Clínica de Fertilidad

    Madrid, Spain

  • Instituto Valenciano de Infertilidad (IVI)

    Seville, Spain

  • Universitäts-Frauenklinik

    Basel, Canton of Basel-City, Switzerland

  • Universitätsklinik für Frauenheilkunde

    Bern, Canton of Bern, Switzerland

  • Prof. Bülent Urman

    Istanbul, Turkey (Türkiye)

  • Ege University

    Izmir, Turkey (Türkiye)

  • Midland Fertility Services

    Aldridge, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.